Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Predictors of SIV recrudescence following antiretroviral treatment interruption.

Pinkevych M, Fennessey CM, Cromer D, Reid C, Trubey CM, Lifson JD, Keele BF, Davenport MP.

Elife. 2019 Oct 25;8. pii: e49022. doi: 10.7554/eLife.49022. [Epub ahead of print]

2.

Estimating Initial Viral Levels during Simian Immunodeficiency Virus/Human Immunodeficiency Virus Reactivation from Latency.

Pinkevych M, Fennessey CM, Cromer D, Tolstrup M, Søgaard OS, Rasmussen TA, Keele BF, Davenport MP.

J Virol. 2018 Jan 2;92(2). pii: e01667-17. doi: 10.1128/JVI.01667-17. Print 2018 Jan 15.

3.

Modeling of Antilatency Treatment in HIV: What Is the Optimal Duration of Antiretroviral Therapy-Free HIV Remission?

Cromer D, Pinkevych M, Rasmussen TA, Lewin SR, Kent SJ, Davenport MP.

J Virol. 2017 Nov 30;91(24). pii: e01395-17. doi: 10.1128/JVI.01395-17. Print 2017 Dec 15.

4.

Genetically-barcoded SIV facilitates enumeration of rebound variants and estimation of reactivation rates in nonhuman primates following interruption of suppressive antiretroviral therapy.

Fennessey CM, Pinkevych M, Immonen TT, Reynaldi A, Venturi V, Nadella P, Reid C, Newman L, Lipkey L, Oswald K, Bosche WJ, Trivett MT, Ohlen C, Ott DE, Estes JD, Del Prete GQ, Lifson JD, Davenport MP, Keele BF.

PLoS Pathog. 2017 May 4;13(5):e1006359. doi: 10.1371/journal.ppat.1006359. eCollection 2017 May.

5.

Correction: HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days-Implications for HIV Remission.

Pinkevych M, Cromer D, Tolstrup M, Grimm AJ, Cooper DA, Lewin SR, Søgaard OS, Rasmussen TA, Kent SJ, Kelleher AD, Davenport MP.

PLoS Pathog. 2016 Aug 25;12(8):e1005745. doi: 10.1371/journal.ppat.1005745. eCollection 2016 Aug.

6.

Modeling of Experimental Data Supports HIV Reactivation from Latency after Treatment Interruption on Average Once Every 5-8 Days.

Pinkevych M, Kent SJ, Tolstrup M, Lewin SR, Cooper DA, Søgaard OS, Rasmussen TA, Kelleher AD, Cromer D, Davenport MP.

PLoS Pathog. 2016 Aug 25;12(8):e1005740. doi: 10.1371/journal.ppat.1005740. eCollection 2016 Aug. No abstract available.

7.

HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days--Implications for HIV Remission.

Pinkevych M, Cromer D, Tolstrup M, Grimm AJ, Cooper DA, Lewin SR, Søgaard OS, Rasmussen TA, Kent SJ, Kelleher AD, Davenport MP.

PLoS Pathog. 2015 Jul 2;11(7):e1005000. doi: 10.1371/journal.ppat.1005000. eCollection 2015 Jul. Erratum in: PLoS Pathog. 2016 Aug;12(8):e1005745.

8.

Modeling the dynamics of Plasmodium vivax infection and hypnozoite reactivation in vivo.

Adekunle AI, Pinkevych M, McGready R, Luxemburger C, White LJ, Nosten F, Cromer D, Davenport MP.

PLoS Negl Trop Dis. 2015 Mar 17;9(3):e0003595. doi: 10.1371/journal.pntd.0003595. eCollection 2015 Mar.

9.

Time-to-infection by Plasmodium falciparum is largely determined by random factors.

Pinkevych M, Chelimo K, Vulule J, Kazura JW, Moormann AM, Davenport MP.

BMC Med. 2015 Jan 30;13:19. doi: 10.1186/s12916-014-0252-9.

10.

Innate immunity induced by Plasmodium liver infection inhibits malaria reinfections.

Liehl P, Meireles P, Albuquerque IS, Pinkevych M, Baptista F, Mota MM, Davenport MP, Prudêncio M.

Infect Immun. 2015 Mar;83(3):1172-80. doi: 10.1128/IAI.02796-14. Epub 2015 Jan 12.

11.

Understanding the relationship between Plasmodium falciparum growth rate and multiplicity of infection.

Pinkevych M, Petravic J, Bereczky S, Rooth I, Färnert A, Davenport MP.

J Infect Dis. 2015 Apr 1;211(7):1121-7. doi: 10.1093/infdis/jiu561. Epub 2014 Oct 9.

PMID:
25301957
12.

Decreased growth rate of P. falciparum blood stage parasitemia with age in a holoendemic population.

Pinkevych M, Petravic J, Chelimo K, Vulule J, Kazura JW, Moormann AM, Davenport MP.

J Infect Dis. 2014 Apr 1;209(7):1136-43. doi: 10.1093/infdis/jit613. Epub 2013 Nov 21.

13.

Density-dependent blood stage Plasmodium falciparum suppresses malaria super-infection in a malaria holoendemic population.

Pinkevych M, Petravic J, Chelimo K, Vulule J, Kazura JW, Moormann AM, Davenport MP.

Am J Trop Med Hyg. 2013 Nov;89(5):850-6. doi: 10.4269/ajtmh.13-0049. Epub 2013 Sep 9.

14.

Gammaherpesvirus latency induces antibody-associated thrombocytopenia in mice.

Freeman ML, Burkum CE, Lanzer KG, Roberts AD, Pinkevych M, Itakura A, Kummer LW, Szaba FM, Davenport MP, McCarty OJ, Woodland DL, Smiley ST, Blackman MA.

J Autoimmun. 2013 May;42:71-9. doi: 10.1016/j.jaut.2012.11.005. Epub 2012 Dec 14.

15.

The dynamics of naturally acquired immunity to Plasmodium falciparum infection.

Pinkevych M, Petravic J, Chelimo K, Kazura JW, Moormann AM, Davenport MP.

PLoS Comput Biol. 2012;8(10):e1002729. doi: 10.1371/journal.pcbi.1002729. Epub 2012 Oct 18.

16.

Drug-induced thrombocytopenia: development of a novel NOD/SCID mouse model to evaluate clearance of circulating platelets by drug-dependent antibodies and the efficacy of IVIG.

Liang SX, Pinkevych M, Khachigian LM, Parish CR, Davenport MP, Chong BH.

Blood. 2010 Sep 16;116(11):1958-60. doi: 10.1182/blood-2010-02-268326. Epub 2010 Jun 21.

PMID:
20566900

Supplemental Content

Loading ...
Support Center